SOSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sosol, and what generic alternatives are available?
Sosol is a drug marketed by Mk Labs and is included in one NDA.
The generic ingredient in SOSOL is sulfisoxazole. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOSOL?
- What are the global sales for SOSOL?
- What is Average Wholesale Price for SOSOL?
Summary for SOSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Patent Applications: | 3,787 |
| DailyMed Link: | SOSOL at DailyMed |
US Patents and Regulatory Information for SOSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mk Labs | SOSOL | sulfisoxazole | TABLET;ORAL | 080036-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
